SCHEMBL10104332

SCHEMBL10104332

Cc1cc(N2CCCN(C)CC2)c(F)c(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.40
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
ASIC3 Q9UHC3 1/20 0.38
NCF1 P14598 1/20 0.38
MAPT P10636 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
SIRT6 Q8N6T7 1/20 0.36
LMNA P02545 1/20 0.36
WDR5 P61964 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104326 0.94 ADRB2 (0.44) ADRB2ALDH1A1KDM4EASIC3MAPT
SCHEMBL10104392 0.88 HTR2A (0.38) ALDH1A1MAPTSMN1; SMN2TSHRHTR2A
SCHEMBL10104375 0.87 ADRB2 (0.41) ADRB2ALDH1A1KDM4EPOLBASIC3
SCHEMBL10104401 0.86 HTR2A (0.37) ALDH1A1TSHRHTR2AHTR2CHTR2B
SCHEMBL10104359 0.84 ADRB2 (0.40) ADRB2ALDH1A1KDM4EPOLBASIC3
SCHEMBL10104374 0.80 ADRB2 (0.45) ADRB2ALDH1A1KDM4EASIC3MAPT
SCHEMBL10104407 0.79 DRD4 (0.36) ADRB2ALDH1A1HTR2AHTR2CHTR2B
SCHEMBL10104333 0.78 ALDH1A1 (0.42) ALDH1A1MAPTLMNASOS1
SCHEMBL10104394 0.78 HSD11B1 (0.36) ADRB2ALDH1A1KDM4EMAPTLMNA
SCHEMBL10104390 0.78 KDM2B (0.39) ALDH1A1KDM4ESMN1; SMN2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110183952-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183952-A1 NEW CHEMICAL COMPOUNDS MKI67, CCNA1, CCNT1 ADRB2 952/4885ALDH1A1 75/4885KDM4E 3042/4885
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 ADRB2 1856/4885ALDH1A1 175/4885KDM4E 2715/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 ADRB2 2202/4885ALDH1A1 860/4885KDM4E 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.